These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6280565)

  • 1. Intercostal muscle biopsy studies in myasthenia gravis: clinical correlations and the direct effects of drugs and myasthenic serum.
    Sanders DB; Kim YI; Howard JF; Johns TR; Muller WH
    Ann N Y Acad Sci; 1981; 377():544-66. PubMed ID: 6280565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum factor blocks neuromuscular transmission in myasthenia gravis: electrophysiologic study with intracellular microelectrodes.
    Shibuya N; Mori K; Nakazawa Y
    Neurology; 1978 Aug; 28(8):804-11. PubMed ID: 210423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desensitization to acetylcholine at motor end plates in normal humans, patients with myasthenia gravis, and experimental models of myasthenia gravis.
    Pagala MK; Namba T; Grob D
    Ann N Y Acad Sci; 1981; 377():567-82. PubMed ID: 6951485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and mechanism of neuromuscular block in myasthenia gravis.
    Grob D; Namba T
    Ann N Y Acad Sci; 1976; 274():143-73. PubMed ID: 183586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis.
    Pagala MK; Nandakumar NV; Venkatachari SA; Ravindran K; Namba T; Grob D
    Muscle Nerve; 1990 Nov; 13(11):1012-22. PubMed ID: 2146496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the molecular mechanisms of human and animal models of myasthenia gravis.
    Albuquerque EX; Warnick JE; Mayer RF; Eldefrawi AT; Eldefrawi ME
    Ann N Y Acad Sci; 1981; 377():496-518. PubMed ID: 6280564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single motor end-plates in myasthenia gravis and LEMS at different firing rates.
    Trontelj JV; Stålberg E
    Muscle Nerve; 1991 Mar; 14(3):226-32. PubMed ID: 1645844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interpretation of end plate potentials (EPP) and miniature end plate potentials (MEPP) by means of the Linc-8-computer, demonstrated with in vitro recordings from intercostal muscle of a patient with myasthenia gravis].
    Kruckenberg P; Bauer H
    Pflugers Arch; 1969; 307(2):R106. PubMed ID: 5814753
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-fiber electromyography in myasthenia gravis.
    Sanders DB; Howard JF; Johns TR
    Neurology; 1979 Jan; 29(1):68-76. PubMed ID: 218146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denervation changes in normal and myasthenia gravis human muscle fibres during organ culture.
    Cull-Candy SG; Miledi R; Uchitel OD
    J Physiol; 1982 Dec; 333():227-49. PubMed ID: 7182466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantal components of end-plate potentials in the myasthenic syndrome.
    Lambert EH; Elmqvist D
    Ann N Y Acad Sci; 1971 Sep; 183():183-99. PubMed ID: 4330759
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles.
    Albuquerque EX; Lebeda FJ; Appel SH; Almon R; Kauffman FC; Mayer RF; Narahashi T; Yeh JZ
    Ann N Y Acad Sci; 1976; 274():475-92. PubMed ID: 1066995
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
    Matsumoto R; Motomura M; Yoshimura T; Kohara N; Kato T
    Rinsho Shinkeigaku; 1999 May; 39(5):531-7. PubMed ID: 10424144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle.
    Johnson BR; Kim YI; Sanders DB
    J Neurol Sci; 1983 Jun; 59(3):431-40. PubMed ID: 6875609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
    Namba T; Nakata Y; Grob D
    Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of fatigue in normal intercostal muscle and muscle from patients with myasthenia gravis.
    Pagala M; Nandakumar NV; Venkatachari SA; Ravindran K; Amaladevi B; Namba T; Grob D
    Muscle Nerve; 1993 Sep; 16(9):911-21. PubMed ID: 8355722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
    Engel AG; Lambert EH
    Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
    Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
    Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-plate potentials in experimental autoimmune myasthenia gravis in rats.
    Lambert EH; Lindstrom JM; Lennon VA
    Ann N Y Acad Sci; 1976; 274():300-18. PubMed ID: 1066990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.